Health Canada - Government of Canada
Skip to left navigationSkip over navigation bars to content
Drugs and Health Products

For Health Professionals

2006

December

arrow Important Safety Information on Attachment Handles for Portable Patient Lifts
- Notice to Hospitals
Date: 2006-12-08

arrow Important Safety Information on Xylocaine (lidocaine HCI) Jelly 2% Single Use Plastic Syringe (10 mL)
- Notice to Hospitals
- AstraZeneca Canada Inc.
Date: 2006-12-06

November

arrow Safety information and corrective action on Air-Shields Isolette C2000/C2000e Infant Incubator
- Notice to Hospitals
- Draeger Medical Canada Inc.
Date: 2006-11-27

arrow Association of Benzocaine Sprays with Methemoglobinemia
- Notice to Hospitals
- For the Public
Date: 2006-11-24

arrow New safety information about Evra (norelgestromin and ethinyl estradiol) Transdermal System
- For Health Professionals
- For the Public
- Janssen-Ortho Inc.
Date: 2006-11-23

arrow Reports of Bowel Obstruction and Gastrointestinal Perforation with Rituxan (rituximab)
- For Health Professionals
- For the Public
- Hoffmann-La Roche Limited
Date: 2006-11-14

October

arrow Association of Avastin (bevacizumab) with hypertensive encephalopathy and reversible posterior leukoencephalopathy syndrome (RPLS)
- For Health Professionals
- For the Public
- Hoffmann - La Roche Limited
Date: 2006-10-27

arrow Association of CellCept (mycophenolate mofetil) and sirolimus containing immunosuppressant regimen with higher rate of acute rejection in cardiac transplant patients switched from calcineurin inhibitors
- For Health Professionals
- For the Public
- Hoffmann-La Roche Limited
Date: 2006-10-25

arrow Association of Syringe Infusion Pumps with a Risk of Delay in Detection of Downstream Occlusion
- Notice to Hospitals
Date: 2006-10-25

arrow Updated Safety Information on Ketek (telithromycin) and hepatic events, aggravation of myasthenia gravis and syncope
- For Health Professionals
- For the Public
- sanofi-aventis Canada Inc.
Date: 2006-10-03

arrow Important Safety Information on Gleevec (imatinib mesylate)
- For Health Professionals
- For the Public
- Novartis Pharmaceuticals Canada Inc.
Date: 2006-10-02

September

arrow Important Safety Information on the Alaris SE Pump (formerly Signature Edition Infusion Pump)
- Notice to Hospitals
- Cardinal Health
Date: 2006-09-19

arrow Important Safety Information on the recall of the Mallinckrodt Satin-Slip Intubating Stylet - 6 FR
- Notice to Hospitals
- Tyco Healthcare Canada
Date: 2006-09-14

August

arrow Association of a Rapamune (sirolimus) containing immunosuppressant regimen with a high rate of acute rejection in de novo renal transplant patients
- For Health Professionals
- For the Public
- Wyeth Pharmaceuticals
Date: 2006-08-24

arrow Association of Lamictal (lamotrigine) with an increased risk of non-syndromic oral clefts
- For Health Professionals
- For the Public
- GlaxoSmithKline Inc.
Date: 2006-08-08

July

arrow Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease
- For Health Professionals
- For the Public
- Schering Canada Inc.
Date: 2006-07-27

arrow Important Safety Information on certain Guidant/Boston Scientific pacemakers and defibrillators
- For Health Professionals
- Guidant Canada Corporation
Date: 2006-07-19

arrow Association of Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy (NSF/NFD) with the use of gadolinium (Omniscan)
- For Health Professionals
- GE Healthcare Canada Inc.
Date: 2006-07-17

arrow Important Safety Information on Specific lots of Comfort Shield Incontinence Care Washcloths
- Notice to Hospitals
- For the Public (2006-06-28)
- Source Medical Corporation
Date: 2006-07-11

arrow Important Safety Information Regarding Intracranial Hemorrhage in Patients Receiving Aptivus (tipranavir) Capsules
- For Health Professionals
- For the Public
- Boehringer Ingelheim (Canada) Ltd
Date: 2006-07-05

June

arrow Important Safety Information on Anzemet (dolasetron mesylate): New Contraindications
- Notice to Hospitals
Date: 2006-06-30

arrow Association of the erectile dysfunction medications Cialis (tadalafil), Levitra (vardenafil hydrochloride) and Viagra (sildenafil citrate) with visual problems
- For Health Professionals
- For the Public
- Eli Lilly Canada Inc.
- Bayer Inc.
- Pfizer Canada Inc.
Date: 2006-06-28

arrow Recall of certain lots of SureStep Blood Glucose Meters
- For Health Professionals
- Notice to Hospitals
- For the Public
- LifeScan Canada Ltd.
Date: 2006-06-22

arrow Important Safety and Efficacy Information on Iressa (gefitinib) 250 mg Tablets
- For Health Professionals
- For the Public
- AstraZeneca Canada Inc.
Date: 2006-06-05

May

arrow Updating of Product Monograph of Attention Deficit Hyperactivity Disorder (ADHD) Drugs
- For Health Professionals
- For the Public
Date: 2006-05-26

arrow Important Safety Information on Evista (raloxifene hydrochloride)
- For Health Professionals
- For the Public
- Eli Lilly Canada Inc
Date: 2006-05-25

arrow Update regarding the association of Tequin (gatifloxacin) with serious hypoglycemia and hyperglycemia
- For Health Professionals
- For the Public
- Bristol-Myers Squibb Canada
Date: 2006-05-17

arrow Important Safety Information on the Colleague Volumetric Infusion Pump
-Baxter Corporation
Date: 2006-05-04

April

arrow Important Safety Information on the recall of Segufix-Standard and Segufix-Simplex
- Segufix Systems Ltd.
Date: 2006-04-28

March

arrow Important Safety Information on the recall of Adult Respiratory Ventilator Circuits
- Source Medical Corporation
Date: 2006-03-22

arrow Important Safety Information on the Potential Delivery of Unrequested Patient-Controlled Analgesia (PCA) Infusion Pump Doses
- Baxter Corporation
Date: 2006-03-16

arrow Important Safety Information on Interference with Medical Telemetry Systems
- Notice to Hospitals
Date: 2006-03-14

arrow Potential Risk of Cutaneous Vasculitic Toxicities associated with the use of Hydrea (hydroxyurea capsules)
- Bristol-Myers Squibb Canada

Date: 2006-03-07

February

arrow Important Safety Information on Trasylol
- Bayer Inc.

Date: 2006-02-28

arrow Important Safety Information on Reprocessing of Mercury-Filled Esophageal Dilators
- Notice to Hospitals
Date: 2006-02-22

arrow Important Safety Information on Octreotide Acetate Omega
- Omega Laboratories, Ltd
Date: 2006-02-15

arrow Important Safety Information on certain Implantable Pacemakers
- Guidant Canada Corporation
Date: 2006-02-09

arrow Important safety information on the Colleague Volumetric Infusion Pump
- For Health Professionals
- Baxter Corporation
Date: 2006-02-07

arrow Important safety information concerning certain ACCU-CHEK Aviva glucose monitors.
- For Health Professionals
- For the Public
- Roche Diagnostics
Date: 2006-02-01

January

arrow Association of WinRho SDF [Rho(D) Immune Globulin (Human)] with Intravascular Hemolysis in the treatment of Immune Thrombocytopenic Purpura
- Notice to Hospitals
- For the Public
- Cangene Corporation
Date: 2006-01-26

arrow Association of Macugen (pegaptanib sodium injection) with hypersensitivity reactions
- For Health Professionals
- For the Public
- Pfizer Canada Inc.
Date: 2006-01-23

arrow Important Safety Information on anti-TNFα Therapy: ENBREL (etanercept), HUMIRA (adalimumab), and REMICADE (infliximab)
- For Health Professionals
- For the Public
- Amgen Canada, Inc., Abbott Laboratories, Ltd., and Schering Canada, Inc.
Date: 2006-01-18

arrow Association of Blood Lancing Devices with Transmission of Blood-Borne Diseases
- Notice to Hospitals
Date: 2006-01-13

Last Updated: 2006-12-08 Top